专题：Acute Lymphoblastic Leukemia research

This cluster of papers focuses on the epidemiology, genetic basis, treatment, and outcomes of childhood acute lymphoblastic leukemia (ALL). It covers topics such as genetic alterations, minimal residual disease, pharmacogenomics, prognostic factors, and relapse risk. The papers also discuss the challenges and advancements in pediatric oncology for the treatment of childhood leukemia.
最新文献
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults

article Full Text OpenAlex

Risk assessment and genetic counseling for hematologic malignancies—Practice resource of the National Society of Genetic Counselors

article Full Text OpenAlex

Effect of rabbit ATG PK on outcomes after TCR-αβ/CD19–depleted pediatric haploidentical HCT for hematologic malignancy

article Full Text OpenAlex

Older MRD vs. younger MUD in patients older than 50 years with AML in remission using post-transplant cyclophosphamide

article Full Text OpenAlex

REXO5 promotes genomic integrity through regulating R-loop using its exonuclease activity

article Full Text OpenAlex

Clinical outcomes of hypomethylating agents and venetoclax in newly diagnosed unfit and relapsed/refractory paediatric, adolescent and young adult acute myeloid leukaemia patients

article Full Text OpenAlex

An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic Leukemia

article Full Text OpenAlex

Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission: results of a randomized phase III study

article Full Text OpenAlex

Taurine and enzymatically modified isoquercitrin protected against methotrexate‐induced deteriorations in the conductivity and rhythmicity of the heart in rats: Antioxidant, anti‐inflammatory, and histological architecture approach

article Full Text OpenAlex

Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study

article Full Text OpenAlex

近5年高被引文献
Brain and other central nervous system tumor statistics, 2021

article Full Text OpenAlex 932 FWCI128.64956017

KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study

article Full Text OpenAlex 686 FWCI54.72203965

Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis

article Full Text OpenAlex 411 FWCI160.34841127

Cisplatin nephrotoxicity: new insights and therapeutic implications

review Full Text OpenAlex 378 FWCI78.14228892

The genomic landscape of pediatric acute lymphoblastic leukemia

article Full Text OpenAlex 338 FWCI98.81720758

Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia

article Full Text OpenAlex 322 FWCI61.45096243

Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022

article Full Text OpenAlex 322 FWCI72.08027139

Natural products: potential treatments for cisplatin-induced nephrotoxicity

review Full Text OpenAlex 320 FWCI44.28764747

Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia

article Full Text OpenAlex 314 FWCI45.85706679

Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations

review Full Text OpenAlex 312 FWCI43.36498815